Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
The mysterious collapse of the Maya civilization may not have been driven solely by drought after all. New evidence from lake sediments in Guatemala reveals that one key city, Itzan, enjoyed a stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results